Immunological effects of a low-dose cytarabine, aclarubicin and granulocyte-colony stimulating factor priming regimen on a mouse leukemia model

The low-dose cytarabine, aclarubicin and granulocyte-colony stimulating factor (G-CSF) (CAG) priming regimen is an effective treatment for patients with relapsed or refractory acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS). G-CSF influences the bone marrow microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinqiu, Yang, Nan, Liu, Hailing, Yao, Huan, Wang, Jin, Yang, Yun, Zhang, Wanggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096276/
https://www.ncbi.nlm.nih.gov/pubmed/30127892
http://dx.doi.org/10.3892/ol.2018.9018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096276/
https://www.ncbi.nlm.nih.gov/pubmed/30127892
http://dx.doi.org/10.3892/ol.2018.9018

Ejemplares similares